DD291925A5 - Arzneimittel enthaltend als wirkstoff dihydroliponsaeure - Google Patents

Arzneimittel enthaltend als wirkstoff dihydroliponsaeure Download PDF

Info

Publication number
DD291925A5
DD291925A5 DD90337679A DD33767990A DD291925A5 DD 291925 A5 DD291925 A5 DD 291925A5 DD 90337679 A DD90337679 A DD 90337679A DD 33767990 A DD33767990 A DD 33767990A DD 291925 A5 DD291925 A5 DD 291925A5
Authority
DD
German Democratic Republic
Prior art keywords
dihydrolipoic acid
acid
optionally
dihydrolipoic
salt
Prior art date
Application number
DD90337679A
Other languages
German (de)
English (en)
Inventor
Heinz Ulrich
Carl-Heinrich Weischer
Juergen Engel
Helmut Hettche
Original Assignee
�������`�����@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������`�����@�������k�� filed Critical �������`�����@�������k��
Publication of DD291925A5 publication Critical patent/DD291925A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD90337679A 1989-02-09 1990-02-07 Arzneimittel enthaltend als wirkstoff dihydroliponsaeure DD291925A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3903758 1989-02-09

Publications (1)

Publication Number Publication Date
DD291925A5 true DD291925A5 (de) 1991-07-18

Family

ID=6373666

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90337679A DD291925A5 (de) 1989-02-09 1990-02-07 Arzneimittel enthaltend als wirkstoff dihydroliponsaeure

Country Status (12)

Country Link
US (1) US5084481A (fr)
EP (1) EP0382066A3 (fr)
JP (1) JPH02240018A (fr)
AU (1) AU622276B2 (fr)
CA (1) CA2009593C (fr)
DD (1) DD291925A5 (fr)
FI (1) FI900625A7 (fr)
HU (2) HUT53286A (fr)
MC (1) MC2094A1 (fr)
NO (1) NO900614L (fr)
PT (1) PT93086B (fr)
ZA (1) ZA90946B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500684B8 (de) * 1989-11-09 2006-11-15 Meda Pharma Gmbh & Co Kg Verwendung von schwefelhältigen carbonsäuren zur herstellung eines arzneimittels zur bekämpfung von erkrankungen durch retroviren
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
ATE315391T1 (de) * 1993-10-11 2006-02-15 Viatris Gmbh Präparat zur behandlung von bluthochdruck.
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
US7438896B2 (en) * 1995-09-20 2008-10-21 N.V. Perricone Llc Method of skin care using lipoic and ascorbic acids
US5709868A (en) * 1995-09-20 1998-01-20 Perricone; Nicholas V. Lipoic acid in topical compositions
US6752999B2 (en) * 1995-09-20 2004-06-22 Nicholas V. Perricone Method of skin care and/or treatment using lipoic acid
US6090915A (en) * 1996-10-18 2000-07-18 Hormel Foods Corporation Collagen or gelatin crumble composition and uses
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
US6472432B1 (en) * 1997-11-17 2002-10-29 Nicholas V. Perricone Treatment of rosacea using lipoic acid
US6090842A (en) 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
WO2000064440A1 (fr) * 1999-04-22 2000-11-02 Department Of The Army, U.S. Government Traitement et/ou prevention des lesions cerebrales et medullaires
US6469049B1 (en) * 2000-04-21 2002-10-22 The United States Of America As Represented By The Secretary Of The Army Method of treating, preventing or inhibiting central nervous system injuries and diseases
EP1476440A4 (fr) * 2002-02-22 2005-06-01 Albany College Of Pharmacy Methodes et composes utiles dans l'inhibition par agression radicalaire et/ou oxydante et dans le traitement et la prevention de maladie
AU2003230644A1 (en) * 2002-03-14 2003-09-29 Ercole L. Cavalieri A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
US20040133938A1 (en) * 2002-11-19 2004-07-08 Yinghui Dan Use of lipoic acid in plant culture media
KR20040097820A (ko) * 2003-05-13 2004-11-18 이기업 알파 리포산을 유효성분으로 함유하는 천식 예방 및치료용 조성물
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US7320805B2 (en) * 2003-10-01 2008-01-22 Institut National De La Sante Et De La Recherche Medicale CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel artifibrogenic pathway in the liver
ITPD20050168A1 (it) * 2005-06-01 2006-12-02 Fidia Advanced Biopolymers Srl Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
US20070225354A1 (en) * 2006-03-21 2007-09-27 Eric Marchewitz Use of dihydrolipoamide for enhancing physical performance
NZ581710A (en) * 2007-06-13 2012-02-24 Jay Pravda Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
WO2014074995A1 (fr) 2012-11-09 2014-05-15 Scidose, Llc Composition de lavement pour le traitement de la colite ulcéreuse ayant une stabilité à long terme

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1134370B (de) * 1958-04-03 1962-08-09 Dr Ulrich Schmidt Verfahren zur Herstellung von 6, 8-Dimercapto-octansaeure
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions
FR3557M (fr) * 1963-12-11 1965-09-20 Biofarma Sa Médicament hépato-protecteur et diurétique.
DE2860317D1 (en) * 1977-12-02 1981-02-19 Troponwerke Gmbh & Co Kg Medicines with sulfur containing esters, and their preparation
EP0078430B2 (fr) * 1981-10-29 1993-02-10 Bayer Ag Procédé de fabrication de préparations pharmaceutiques solides à libération rapide de dihydropyridines
EP0159519A3 (fr) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Utilisation de composés thio pour prévenir la chute des cheveux provoquée par des cytostatiques
EP0318891B1 (fr) * 1987-12-04 1992-01-02 ASTA Medica Aktiengesellschaft Solution injectable de l'acide thioctique contenant du trometamole et/ou des acides aminés basiques

Also Published As

Publication number Publication date
AU622276B2 (en) 1992-04-02
CA2009593C (fr) 1998-12-01
AU4936890A (en) 1990-08-16
NO900614D0 (no) 1990-02-08
HU210607A9 (en) 1995-05-29
EP0382066A3 (fr) 1992-01-08
US5084481A (en) 1992-01-28
CA2009593A1 (fr) 1990-08-09
FI900625A7 (fi) 1990-08-10
FI900625A0 (fi) 1990-02-08
EP0382066A2 (fr) 1990-08-16
PT93086B (pt) 1997-01-31
MC2094A1 (fr) 1991-02-15
ZA90946B (en) 1990-11-28
HU900729D0 (en) 1990-04-28
PT93086A (pt) 1990-08-31
NO900614L (no) 1990-08-10
HUT53286A (en) 1990-10-28
JPH02240018A (ja) 1990-09-25

Similar Documents

Publication Publication Date Title
DD291925A5 (de) Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
DE4035442B4 (de) Arzneimittel enthaltend als Wirkstoff R-α-Liponsäure
EP0467164B1 (fr) Flupirtine en combinaison avec antiparkinsonica pour lutter contre la raideur musculaire
EP0241809B1 (fr) Association synergétique d'amantadine et de sélégiline
EP0189788B1 (fr) Combinaison synergétique de flupirtine et d'anti-phlogistiques non-stéroidaux
DE4218572A1 (de) Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
EP0396069B1 (fr) Sels d'azélastine à solubilité améliorée
DE4035456A1 (de) Arzneimittel, welche als wirkstoff schwefel enthaltende carbonsaeuren enthalten sowie deren verwendung zur bekaempfung von retroviren
EP0378086A2 (fr) Utilisation de l'agent azélastine pour le traitement du psoriasis
EP0204989B1 (fr) Utilisation de la pénicillamine pour le traitement des maladies d'immuno-dépression
EP0277352B1 (fr) Association synergétique d'azélastine et de théophylline ou d'azélastine et de bêta-mimétiques
DE2624558A1 (de) Arzneimittel mit analgetischer wirkung
DE69822626T2 (de) Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs
DE4029747C2 (de) Verwendung von Hexadecylphosphocholin zur Behandlung von Psoriasis-Erkrankungen
DE4420102A1 (de) Arzneimittelkombinationen aus alpha-Liponsäure und herz-kreislaufaktiven Substanzen
DE4002706A1 (de) Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
CH660556A5 (de) Therapeutische zubereitung zur behandlung von kardiovaskulaeren krankheiten.
DE4327462A1 (de) Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen
DE4333794A1 (de) Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie
DE4331168A1 (de) Kombination von N-Acetyl-p-Aminophenol mit schwefelenthaltenden Carbonsäuren, wie z. B. alpha-Liponsäure und deren Derivate, zur Bekämpfung von Schmerzzuständen
DE2520483A1 (de) Phenoxy-isobuttersaeurederivate und diese verbindungen enthaltende arzneimittel
DE3710966A1 (de) Synergistische kombination von amantadin und selegilin
DE2131946A1 (de) Salze der Orotsaeure mit Aminoalkoholen sowie Verfahren zu deren Herstellung und Anwendung
DE3601195A1 (de) Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika
DE3038401A1 (de) Oxayohimban-carbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee